Clinical Trials for Metastatic Pancreatic Cancer

Find clinical trials for metastatic pancreatic cancer. Discover research opportunities and treatment options in your area.

43 Active Trials Found

Showing 43 trials on this page

Page 1 of 3

The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation

NCT ID: NCT06843551

The Miami "EMPIRE" Trial is a clinical study looking at a new treatment approach for patients with metastatic pancreatic cancer, specifically a type called pancreatic ductal adenocarcinoma. The res...

Recruiting

Phase: PHASE2 Type: interventional Locations: Miami, Florida, United States

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients

NCT ID: NCT05065801

This clinical trial is studying a new treatment approach for patients with metastatic pancreatic cancer, which means the cancer has spread from the pancreas to other parts of the body. The research...

Recruiting

Phase: PHASE2 Type: interventional Locations: Perpignan, , France, Dijon, , France +14 more

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

NCT ID: NCT04753879

This clinical trial is studying a new treatment approach for patients with metastatic pancreatic ductal cancer, which means the cancer has spread beyond the pancreas. The trial looks at the safety ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Baltimore, Maryland, United States

A Phase II Study to Evaluate GFH375 in Patients With KRAS G12D Mutant Metastatic Pancreatic Cancer

NCT ID: NCT07026916

This clinical trial is studying a new medicine called GFH375 to see if it can help people with metastatic pancreatic cancer, a type of cancer that has spread to other parts of the body. Specificall...

Not yet recruiting

Phase: PHASE2 Type: interventional

Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients

NCT ID: NCT05929885

This clinical trial is exploring a new treatment approach for patients with metastatic pancreatic cancer, which is cancer that has spread beyond the pancreas and is not curable through surgery. The...

Recruiting

Phase: PHASE2 Type: interventional Locations: Singapore, , Singapore

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

NCT ID: NCT01174121

This clinical trial is studying a new treatment for patients with advanced cancers, including metastatic colorectal, pancreatic, ovarian, breast cancers, and neuroendocrine tumors. The treatment in...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bethesda, Maryland, United States, Bethesda, Maryland, United States

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

NCT ID: NCT03682289

This clinical trial is investigating a new treatment called Ceralasertib (AZD6738) for patients with various types of solid tumors, including kidney cancer, pancreatic cancer, and endometrial cance...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States, Duarte, California, United States +1 more

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT ID: NCT04222413

This clinical trial is studying a new drug called metarrestin, which researchers hope can help stop cancer cells from growing and spreading, particularly in patients with advanced solid tumors like...

Recruiting

Phase: PHASE1 Type: interventional Locations: Bethesda, Maryland, United States, Fairway, Kansas, United States

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

NCT ID: NCT06533332

This clinical trial is studying a new treatment called ERX-315 for people with advanced solid tumors, which are cancers that form in tissues like the breast, ovaries, pancreas, liver, and uterus. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Adelaide, South Australia, Australia, Sydney, New South Wales, Australia +1 more

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

NCT ID: NCT04665947

This clinical trial is studying a new treatment approach for patients with advanced pancreatic cancer, specifically those whose cancer cannot be surgically removed (locally advanced) or has spread ...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Sacramento, California, United States

A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer

NCT ID: NCT06168812

This clinical trial is studying a medication called glipizide to see if it can help lower high blood sugar levels in people diagnosed with pancreatic cancer. The researchers want to find out if gli...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +5 more

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

NCT ID: NCT05737615

This clinical trial is studying a new imaging technique that uses a special substance called hu5B1-TCO and a radioactive material known as 64Cu-Tz-SarAr. The goal is to find the safest dose of thes...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States

QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer

NCT ID: NCT06951997

This clinical trial is designed to test a new treatment for patients with metastatic pancreatic cancer, which means the cancer has spread beyond the pancreas. The study will investigate the combina...

Not yet recruiting

Phase: PHASE2 Type: interventional

Redefining FOLFIORINOX in Older Pancreatic Cancer Patients

NCT ID: NCT05360732

The clinical trial titled "Redefining FOLFIORINOX in Older Pancreatic Cancer Patients" is exploring a new treatment approach for older adults diagnosed with metastatic pancreatic cancer, which mean...

Recruiting

Phase: PHASE2 Type: interventional Locations: Philadelphia, Pennsylvania, United States

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

NCT ID: NCT06483555

This clinical trial is looking at a new treatment approach for patients with advanced pancreatic cancer, specifically a subtype known as basal-like pancreatic adenocarcinoma. Researchers want to fi...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

NCT ID: NCT04820179

This clinical trial is investigating a new treatment approach for patients with advanced pancreatic cancer that has not responded to previous therapies. The study is looking at a combination of two...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tucson, Arizona, United States

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

NCT ID: NCT04605913

This clinical trial is exploring a new treatment approach for patients with metastatic pancreatic cancer, which means the cancer has spread beyond the pancreas to other parts of the body. The study...

Recruiting

Phase: PHASE1 Type: interventional Locations: Jacksonville, Florida, United States, Jacksonville, Florida, United States

Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer

NCT ID: NCT04901741

This clinical trial is exploring a new treatment approach for patients with metastatic pancreatic cancer, a type of cancer that has spread beyond its original site. The study is looking at a combin...

Not yet recruiting

Phase: PHASE2 Type: interventional

The Effect of Isoquercetin on Thromboembolic Events in Patients with Metastatic Pancreatic Cancer

NCT ID: NCT06861088

This clinical trial is studying a substance called isoquercetin to see if it can help prevent blood clots in patients with advanced pancreatic cancer. Blood clots can be a serious issue for these p...

Not yet recruiting

Phase: PHASE3 Type: interventional

Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy

NCT ID: NCT05927142

This clinical trial is investigating a new treatment approach for patients with metastatic pancreatic ductal adenocarcinoma (PDAC), which is a type of pancreatic cancer that has spread beyond the p...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rotterdam, Zuid Holland, Netherlands

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions